These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 10600812)

  • 21. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
    Sito E; Konturek PC; Bielański W; Kwiecień N; Konturek SJ; Baniukiewicz A; Jedynak M; Gabryelewicz A; Hahn EG
    J Physiol Pharmacol; 1996 Mar; 47(1):221-8. PubMed ID: 8777303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.
    Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE
    Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
    Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
    Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients.
    Konturek JW; Gillessen A; Konturek SJ; Domschke W
    Gut; 1995 Oct; 37(4):482-7. PubMed ID: 7489932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Bloemena E; Nelis GF; Festen HP; Jansen EH; Biemond I; Lamers CB; Meuwissen SG
    Aliment Pharmacol Ther; 1998 Jul; 12(7):605-12. PubMed ID: 9701523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients. A controlled study.
    Parente F; Maconi G; Sangaletti O; Minguzzi M; Vago L; Bianchi Porro G
    Gut; 1995 Aug; 37(2):210-5. PubMed ID: 7557570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
    Rindi G; Fiocca R; Morocutti A; Jacobs A; Miller N; Thjodleifsson B;
    Eur J Gastroenterol Hepatol; 2005 May; 17(5):559-66. PubMed ID: 15827447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.
    Gillen D; Wirz AA; McColl KE
    Gastroenterology; 2004 Apr; 126(4):980-8. PubMed ID: 15057737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis.
    Yasunaga Y; Shinomura Y; Kanayama S; Yabu M; Nakanishi T; Miyazaki Y; Murayama Y; Bonilla-Palacios JJ; Matsuzawa Y
    Gut; 1994 Nov; 35(11):1571-4. PubMed ID: 7828975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men.
    Katelaris PH; Seow F; Lin BP; Napoli J; Ngu MC; Jones DB
    Gut; 1993 Aug; 34(8):1032-7. PubMed ID: 8174948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of H pylori on plasma ghrelin in patients without atrophic gastritis.
    Cindoruk M; Yetkin I; Deger SM; Karakan T; Kan E; Unal S
    World J Gastroenterol; 2007 Mar; 13(10):1595-8. PubMed ID: 17461454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.
    Hirschowitz BI; Simmons J; Mohnen J
    Aliment Pharmacol Ther; 2002 Feb; 16(2):303-13. PubMed ID: 11860414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
    Tokushima H; Tamura H; Matsumura O; Murakawa M; Itakura Y; Itoyama S; Mitarai T; Isoda K
    Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):349-55. PubMed ID: 8828354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.
    Konturek JW; Bielański W; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori modulation of gastric acid.
    Calam J
    Yale J Biol Med; 1999; 72(2-3):195-202. PubMed ID: 10780581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.